Related Experiment Video
Updated: Aug 15, 2026

High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model
Published on: March 16, 2022
Distal lower extremity paresthesia and foot drop developing during adalimumab therapy
Cindy N Berthelot1, Saira J George, Sylvia Hsu
1University of Texas Medical School Southwestern, Dallas, Texas, USA.
Abstract:
The development of tumor necrosis factor inhibitor biologic therapy is arguably one of the most significant achievements in the treatment of rheumatic diseases to date. Neurologic events suggestive of demyelination have been reported for patients receiving treatment with the antitumor necrosis factor agents etanercept and infliximab. We describe the onset of lower extremity paresthesia and foot drop in a patient who was receiving adalimumab for the treatment of psoriasis and examine the relationship of tumor necrosis factor antagonism and demyelinating disease.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Foot Ulcer
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease I: Introduction
Pulse Assessment Sites
Peripheral Artery Disease V: Postoperative Nursing Management